Fig. 2From: Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor designA graphical workflow of the methods and tools (in brackets) used in sequence and structural analysis of FP-2, FP-3 and their homologsBack to article page